Fas ligond expression in glioblastoma cell lines and primary astrocytic brain tumors

Brain Pathology

Volumn 7, Issue 3, 1997, Pages 863-869

  Gratas, Catherine ^a   Tohma, Yasuo ^a   Van Meir, Erwin G ^c   Klein, Michael ^b   Tenan, Mirna ^c   Ishii, Nobuaki ^c   Tachibana, Osamu ^a   Kleihues, Paul ^a,b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; CANCER GRADING; CARCINOGENESIS; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADULT; AGED; APOPTOSIS; BIOSYNTHESIS; BRAIN TUMOR; CELL CULTURE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION;

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; LIGAND; MEMBRANE PROTEIN; TUMOR ANTIGEN;

ADULT; AGED; ANTIGENS, CD95; ANTIGENS, NEOPLASM; APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; FAS LIGAND PROTEIN; FEMALE; GLIOBLASTOMA; HUMANS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030610033     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1997.tb00889.x     Document Type: Article

References (37)

1. Alderson MR, Tough TW, Davis Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181: 71-77
2. Barker FG, Davis RL, Chang SM, Prados MD (1996) Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 77: 1161-1166
3. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
4. Burger PC Scheithauer BW (1994) Tumors of the Central Nervous System. Armed Forces Institute of Pathology: Washington, DC
5. Cheng J, Liu C, Koopman WJ, Mountz JD (1995) Characterization of human Fas gene. Exon/intron organization and promoter region. J Immunol 154: 1239-1245
6. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762
7. Choimczynski R Sacchi N (1987) Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
8. Daumas Duport C, Scheithauer B, O'Fallon J, Kelly P (1988) Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152-2165
9. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184: 1513-1518
10. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher IM, Bran L, Benhattar J, Tada M, Van Meir EG, EstreicherA, Iggo RD (1995) A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92: 3963-3967
11. French LE, Hahne M, Viard I, Radigruber G, Zanone R, Becker K, Muller C, Tschopp J (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133: 335-343
12. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192
13. Hahne M, Renno T, Schroeter M, Irmler M, French L, Bernard T, MacDonald HR, Tschopp J (1996) Activated B cells express functional Fas ligand. Eur J Immunol 26: 721-724
14. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bomand T, Fontana A, Lienard D, Cerottini J-C, Tschopp J (1996) Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363-1366
15. Jain RK (1988) Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658
16. Kleihues P, Burger PC, Scheithauer BW (1993) Histological Typing of Tumours of the Central Nervous System. World Health Organization International Histological Classification of Tumours. 2nd edition, Springer Verlag: Berlin, Heidelberg
17. Kleihues P, Ohgaki H, Aguzzi A (1995) Neuroglia. In: Gliomas, Kettenmann H, Ransom BR (eds.), pp. 1044-1063. Oxford University Press: Oxford
18. Knipping E, Debatin KM, Stncker K, Heilig B, Eder A, Krammer PH (1995) identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 85: 1562-1569
19. Koji T, Kobayashi N, Nakanishi Y, Yoshi A (1994) immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cytochem 27: 459-463
20. Kordek R, Hironishi M, Liberski PP, Yanagihara R, Gajdusek DC (1996) Apoptosis in glial tumors as determined by in situ nonradioactive labeling of DMA breaks. Acta Neuropathol Berl 91: 112-116
21. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69: 415-429
22. Loughran TP, Jr. (1993) Clonal diseases of large granular lymphocytes. Blood 82: 1-14
23. Nagata S, Golstein P (1995) The Fas death factor. Science 267: 1449-1456
24. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F (1996) The Fas-counterattack: Fas-mediated T-cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184: 1075-1082
25. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848
26. Plate KH, Risau W (1995) Angiogenesis in malignant gliomas. Glia 15: 339-347
27. Sawamura Y, de Tribolet N (1990) Advances and technical standards in neurosurgery. In: Immunobiology of Brain Tumors, Symon L, Calliauw L, Cohadon F, Guidetti B, Loew F, Nornes H, Pasztor E, Pertuiset B, Pickard JD, Yasargil MG (eds.), pp. 3-64, Springer-Vertag: Vienna, New York
28. Schiffer D, Cavalla P, Migheli A, Chio A, Giordana MT, Marino S, Attanasio A (1995) Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci Lett 195. 81-84
29. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endotheliagrowth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845
30. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Manani SM, Stremmel W, Krammer PH, Galle PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? Nat Med 2: 1361-1366
31. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas tigand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178
32. Tachibana O, Lampe K, Kleihues P, Ohgaki H (1996) Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of the glioblastoma multiforme. Acta Neuropathol 92: 431-434
33. Tachibana O, Nakazawa H, Lampe J, Watanabe K, Kleihues P, Ohgaki H (1995) Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res 55: 5528-5530
34. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6: 1567-1574
35. Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE, Huang HJ, Friedmann T, de Tribolet N, Cavenee WK (1994) Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54: 649-652
36. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S (1992) The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274-1279
37. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964